JP2013512920A5 - - Google Patents

Info

Publication number

JP2013512920A5

JP2013512920A5 JP2012542204A JP2012542204A JP2013512920A5 JP 2013512920 A5 JP2013512920 A5 JP 2013512920A5 JP 2012542204 A JP2012542204 A JP 2012542204A JP 2012542204 A JP2012542204 A JP 2012542204A JP 2013512920 A5 JP2013512920 A5 JP 2013512920A5

Authority

JP

Japan

Prior art keywords

seq

light chain

heavy chain

variable

domain

Prior art date

2010-12-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 150000001413 amino acids Chemical group 0.000 claims 84
• 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims 64
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims 35
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims 35
• 239000003814 drug Substances 0.000 claims 17
• 206010028980 Neoplasm Diseases 0.000 claims 14
• 229940124597 therapeutic agent Drugs 0.000 claims 13
• 239000002773 nucleotide Substances 0.000 claims 11
• 125000003729 nucleotide group Chemical group 0.000 claims 11
• 210000004027 cell Anatomy 0.000 claims 9
• 238000011144 upstream manufacturing Methods 0.000 claims 8
• 108090000790 Enzymes Proteins 0.000 claims 7
• 102000004190 Enzymes Human genes 0.000 claims 7
• 201000011510 cancer Diseases 0.000 claims 7
• 239000000975 dye Substances 0.000 claims 7
• 206010005003 Bladder cancer Diseases 0.000 claims 6
• 206010006187 Breast cancer Diseases 0.000 claims 6
• 208000026310 Breast neoplasm Diseases 0.000 claims 6
• 206010009944 Colon cancer Diseases 0.000 claims 6
• 208000001333 Colorectal Neoplasms Diseases 0.000 claims 6
• 208000008839 Kidney Neoplasms Diseases 0.000 claims 6
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims 6
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims 6
• 206010060862 Prostate cancer Diseases 0.000 claims 6
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims 6
• 206010038389 Renal cancer Diseases 0.000 claims 6
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 6
• 239000000032 diagnostic agent Substances 0.000 claims 6
• 229940039227 diagnostic agent Drugs 0.000 claims 6
• 201000010982 kidney cancer Diseases 0.000 claims 6
• 201000007270 liver cancer Diseases 0.000 claims 6
• 208000014018 liver neoplasm Diseases 0.000 claims 6
• 201000005202 lung cancer Diseases 0.000 claims 6
• 208000020816 lung neoplasm Diseases 0.000 claims 6
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 6
• 201000001441 melanoma Diseases 0.000 claims 6
• 201000002528 pancreatic cancer Diseases 0.000 claims 6
• 208000008443 pancreatic carcinoma Diseases 0.000 claims 6
• 201000005112 urinary bladder cancer Diseases 0.000 claims 6
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 5
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 5
• 101710163270 Nuclease Proteins 0.000 claims 5
• 108091034117 Oligonucleotide Proteins 0.000 claims 5
• 239000002246 antineoplastic agent Substances 0.000 claims 5
• 239000000074 antisense oligonucleotide Substances 0.000 claims 5
• 238000012230 antisense oligonucleotides Methods 0.000 claims 5
• 150000001639 boron compounds Chemical class 0.000 claims 5
• 239000002738 chelating agent Substances 0.000 claims 5
• 239000003795 chemical substances by application Substances 0.000 claims 5
• 229940127089 cytotoxic agent Drugs 0.000 claims 5
• 239000005556 hormone Substances 0.000 claims 5
• 229940088597 hormone Drugs 0.000 claims 5
• 239000002955 immunomodulating agent Substances 0.000 claims 5
• 229940121354 immunomodulator Drugs 0.000 claims 5
• 230000002584 immunomodulator Effects 0.000 claims 5
• 239000000906 photoactive agent Substances 0.000 claims 5
• -1 radioisotope Proteins 0.000 claims 5
• 230000001225 therapeutic effect Effects 0.000 claims 5
• 239000003053 toxin Substances 0.000 claims 5
• 231100000765 toxin Toxicity 0.000 claims 5
• 108010076504 Protein Sorting Signals Proteins 0.000 claims 4
• 238000004519 manufacturing process Methods 0.000 claims 4
• 230000028327 secretion Effects 0.000 claims 4
• 150000001875 compounds Chemical class 0.000 claims 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
• 210000004899 c-terminal region Anatomy 0.000 claims 2
• 239000002872 contrast media Substances 0.000 claims 2
• 235000018417 cysteine Nutrition 0.000 claims 2
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 2
• 239000003623 enhancer Substances 0.000 claims 2
• 239000002082 metal nanoparticle Substances 0.000 claims 2
• 238000000034 method Methods 0.000 claims 2
• 239000002096 quantum dot Substances 0.000 claims 2
• 239000000941 radioactive substance Substances 0.000 claims 2
• 235000001014 amino acid Nutrition 0.000 claims 1
• 239000007850 fluorescent dye Substances 0.000 claims 1
• 238000003384 imaging method Methods 0.000 claims 1
• 238000001727 in vivo Methods 0.000 claims 1
• 239000008194 pharmaceutical composition Substances 0.000 claims 1
• 239000007787 solid Substances 0.000 claims 1
• 230000008685 targeting Effects 0.000 claims 1